Federman & Sherwood Announces That a Securities Class Action LawsuitHas Been Filed Against Chelsea Therapeutics International Ltd.CHTP
OKLAHOMA CITY, OK, Apr 06, 2012 (Menafn - MARKETWIRE via COMTEX) --On April 4, 2012, a class action lawsuit was filed in the UnitedStates District Court for the Western District of North Carolinaagainst Chelsea Therapeutics International Ltd. CHTP. Thecomplaint alleges violations of federal securities laws, Sections10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule10b-5, including allegations of issuing a series of material or falsemisrepresentations to the market which had the effect of artificiallyinflating the market price during the Class Period, which is November3, 2008 through March 28, 2012.
Plaintiff seeks to recover damages on behalf of all ChelseaTherapeutics International Ltd. shareholders who purchased commonstock during the Class Period and are therefore a member of the Classas described above. You may move the Court no later than Monday, June4, 2012 to serve as a lead plaintiff for the entire Class. However,in order to do so, you must meet certain legal requirements pursuantto the Private Securities Litigation Reform Act of 1995.
If you wish to discuss this action, obtain further information andparticipate in this or any other securities litigation, or should youhave any questions or concerns regarding this notice or preservationof your rights, please contact:
K. Lynn Nunn
FEDERMAN & SHERWOOD
10205 North Pennsylvania Avenue
Oklahoma City, OK 73120
Email to: firstname.lastname@example.org
Or, visit our website at www.federmanlaw.com
SOURCE: Federman & Sherwood
Copyright 2012 Marketwire, Inc., All rights reserved.